Exhibiting at the European Neuro Convention

Clavicont Ltd.

Clavicont facilitates early detection and measuring progression of Parkinson`s disease.
The method is evidence based by observing and processing sensorimotor signals during typing. In the early stage there might be no visible tremor or any kind of visible alteration of movement, however temporal data obtained from any common keyboard processed with our algorithms can represent motor control quality and possible deterioration. We derive essential indicators from the keystroke stream.
We provide the whole methodology of usage for hospitals and for clinics. Implementation is fast and simple.
Clavicont can be used for early detection, for monitoring and for therapy control.
We also provide consultancy in neurology and chanel to change experiences with other clinics.

Visit Website


Exhibitor product 1Exhibitor product 2Exhibitor product 3